Abstract
High-risk pulmonary embolism (PE) patients can be managed with systemic lysis, catheter-based therapies, or surgical embolectomy. Despite the advent of newer therapies, patients with high-risk PE remain with a 50–60% short-term mortality risk. In such patients, extracorporeal membrane oxygenation (ECMO) is increasingly utilized for hemodynamic support. To evaluate the outcomes of the use of ECMO in patients with high-risk PE. Using the National Inpatient Sample (NIS) database, we identified patients with high-risk PE using ICD 10 codes and compared in-hospital outcomes of patients with and without ECMO support. We identified 38,035 patients with high-risk PE, of whom 820 had undergone ECMO placement. Most patients who underwent ECMO were male (54%), white (65%), and with a mean age of 53.7 years. ECMO use was not associated with a meaningful difference in patient mortality when comparing treatment groups (OR, 1.32 ± 0.39; 0.74–2.35; p = 0.35). Rather, ECMO use was associated with a higher frequency of inpatient complications. ECMO use was not associated with a significant difference in patient mortality in patients with high-risk PE.
Highlights
-
Of 38,035 patients identified in an administrative database to have high risk pulmonary embolism, outcomes were evaluated for those who underwent mechanical cardiac support with extracorporeal membrane oxygenation for right ventricular failure.
-
After propensity-matching, 1560 patients (one-half with extracorporeal membrane oxygenation), length of hospital stay was longer if mechanical cardiac assistance was instituted and 40% of patients ultimately died.
-
Overall, extracorporeal membrane oxygenation did not improve patient mortality in the context of high-risk pulmonary embolism, and increased the frequency of gastrointestinal bleeding, blood transfusion requirements, vascular access complications, and acute kidney injury.
Similar content being viewed by others
Data availability
Data or code will be made available on request from the first author: Dr. Farhan Nasser: farhannasser@gmail.com
References
Heit JA (2008) The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 28(3):370–372. https://doi.org/10.1161/ATVBAHA.108.162545
Goldhaber SZ, Bounameaux H (2012) Pulmonary embolism and deep vein thrombosis. The Lancet 379(9828):1835–1846
Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM (2018) Epidemiology, pathophysiology, and natural history of pulmonary embolism. Semin Intervent Radiol 35(2):92–98
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL, ESC Scientific Document Group (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 41(4):543–603
Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). The Lancet 353(9162):1386–1389
Vandenbriele C, Van Edom C, Tavazzi G. Anticoagulant management for transition from failed thrombolysis to extra-corporeal membrane oxygenation in patients with high-risk pulmonary embolism: A thoughtful approach. International Journal of Cardiology [Internet]. 22 Oct 2022 [cited 27 Nov 2022]; Available from: https://www.sciencedirect.com/science/article/pii/S0167527322016497
Tamariz L, Harkins T, Nair V (2012) A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiol Drug Saf 21(Suppl 1):154–162
Smith SB, Geske JB, Kathuria P, Cuttica M, Schimmel DR, Courtney DM, Waterer GW, Wunderink RG (2016) Analysis of national trends in admissions for pulmonary embolism. Chest 150(1):35–45
Elbadawi A, Mentias A, Elgendy IY, Mohamed AH, Syed MH, Ogunbayo GO, Olorunfemi O, Gosev I, Prasad S, Cameron SJ (2019) National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism. Vasc Med 24(3):230–233
Corsi F, Lebreton G, Bréchot N, Hekimian G, Nieszkowska A, Trouillet JL, Luyt CE, Leprince P, Chastre J, Combes A, Schmidt M (2017) Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation. Crit Care 21(1):76
George B, Parazino M, Omar HR, Davis G, Guglin M, Gurley J, Smyth S (2018) A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support. Resuscitation 1(122):1–5
Baldetti L, Beneduce A, Cianfanelli L, Falasconi G, Pannone L, Moroni F, Venuti A, Sacchi S, Gramegna M, Pazzanese V, Calvo F, Gallone G, Pagnesi M, Cappelletti AM (2021) Use of extracorporeal membrane oxygenation in high-risk acute pulmonary embolism: a systematic review and meta-analysis. Artif Organs 45(6):569–576
Pozzi M, Metge A, Martelin A, Giroudon C, Lanier Demma J, Koffel C, Fornier W, Chiari P, Fellahi JL, Obadia JF, Armoiry X (2020) Efficacy and safety of extracorporeal membrane oxygenation for high-risk pulmonary embolism: a systematic review and meta-analysis. Vasc Med 25(5):460–467
Alhussein M, Moayedi Y, Posada JD, Ross H, Hickey E, Rao V, Billia F (2017) Ventricular thrombosis post-venoarterial extracorporeal membrane oxygenation. Circ Heart Fail 10(2):e003757
Vandenbriele C, Arachchillage DJ, Frederiks P, Giustino G, Gorog DA, Gramegna M, Janssens S, Meyns B, Polzin A, Scandroglio M, Schrage B, Stone GW, Tavazzi G, Vanassche T, Vranckx P, Westermann D, Price S, Chieffo A (2022) Anticoagulation for percutaneous ventricular assist device-supported cardiogenic shock: JACC review topic of the week. J Am Coll Cardiol 79(19):1949–1962
Murphy DA, Hockings LE, Andrews RK, Aubron C, Gardiner EE, Pellegrino VA, Davis AK (2015) Extracorporeal membrane oxygenation—hemostatic complications. Transfus Med Rev 29(2):90–101
Meneveau N, Guillon B, Planquette B, Piton G, Kimmoun A, Gaide-Chevronnay L, Aissaoui N, Neuschwander A, Zogheib E, Dupont H, Pili-Floury S, Ecarnot F, Schiele F, Deye N, de Prost N, Favory R, Girard P, Cristinar M, Ferré A, Meyer G, Capellier G, Sanchez O (2018) Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J 39(47):4196–4204
Pasrija C, Kronfli A, Rouse M, Raithel M, Bittle GJ, Pousatis S, Ghoreishi M, Gammie JS, Griffith BP, Sanchez PG, Kon ZN (2018) Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience. J Thorac Cardiovasc Surg 155(3):1095-1106.e2
Goldberg JB, Spevack DM, Ahsan S, Rochlani Y, Dutta T, Ohira S, Kai M, Spielvogel D, Lansman S, Malekan R (2020) Survival and right ventricular function after surgical management of acute pulmonary embolism. J Am Coll Cardiol 76(8):903–911
Giraud R, Legouis D, Assouline B, De Charriere A, Decosterd D, Brunner ME, Moret-Bochatay M, Fumeaux T, Bendjelid K (2021) Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients. Physiol Rep 9(3):e14715
Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, Naar J, Smalcova J, Hubatova M, Hromadka M, Volovar S, Seyfrydova M, Jarkovsky J, Svoboda M, Linhart A, Belohlavek J (2022) extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.122.062949
Funding
Funding support from the National Institutes of Health, R01HL158801 (to SJC).
Author information
Authors and Affiliations
Contributions
M.F.N, A.J: conceptualization. M.F.N, A.J: methodology and analysis. M.F.N, S.S, V.K, S.C: writing: review and editing. L.A, Y.A.O: editing and figure design. S.C: supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nasser, M.F., Jabri, A., Sharma, S. et al. Outcomes with use of extra-corporeal membrane oxygenation in high-risk pulmonary embolism: a national database perspective. J Thromb Thrombolysis 55, 499–505 (2023). https://doi.org/10.1007/s11239-023-02773-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-023-02773-2